This website uses cookies to function correctly.
You may delete cookies at any time but doing so may result in some parts of the site not working correctly.
 

Emerade (adrenaline autoinjector)

Important information for users of Emerade (adrenaline autoinjector)



The makers of Emerade have advised there is a risk of needle blockage leading to Emerade failing to deliver a dose of adrenaline.


The risk is low, 2.3 in every thousand pens, however patients are advised carry two in-date pens with them at all times.


The product is not being recalled.   Published: 16 July 2019



 
Call 111 when you need medical help fast but it’s not a 999 emergencyNHS ChoicesThis site is brought to you by My Surgery Website